Loading clinical trials...
Loading clinical trials...
This study aims to evaluate the clinical feasibility of adopting artificial intelligence (AI)-based models to improve clinical management of thyroid cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Hong Kong
Collaborators
NCT00001160 · Hurthle Cell Thyroid Cancer, Tall Cell Variant Thyroid Cancer, and more
NCT07600580 · Thyroid Cancer, Thyroid and Parathyroid Surgery, and more
NCT06851663 · Solid Tumor, Solid Carcinoma, and more
NCT06671184 · Differentiated Thyroid Cancer
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
Department of Surgery, School of Clinical Medicine, The University of Hong Kong
Hong Kong
School of Public Health, The University of Hong Kong
Hong Kong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions